Total Payments
$8,493
2024 Payments
$1,958
Companies
31
Transactions
447
Medicare Patients
725
Medicare Billing
$128,601
Payment Breakdown by Category
Food & Beverage$8,417 (99.1%)
Education$76.00 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,417 | 446 | 99.1% |
| Education | $76.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,135 | 137 | $0 (2024) |
| Gilead Sciences, Inc. | $1,191 | 31 | $0 (2024) |
| ABBVIE INC. | $858.87 | 50 | $0 (2024) |
| Celgene Corporation | $541.63 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $507.68 | 22 | $0 (2024) |
| QOL Medical, LLC | $380.61 | 18 | $0 (2024) |
| PFIZER INC. | $349.72 | 19 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $302.86 | 14 | $0 (2024) |
| RedHill Biopharma Inc. | $284.70 | 20 | $0 (2024) |
| Ardelyx, Inc. | $250.52 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,958 | 104 | ABBVIE INC. ($241.29) |
| 2023 | $1,744 | 104 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($343.29) |
| 2022 | $1,495 | 87 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($436.51) |
| 2021 | $708.50 | 47 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($210.10) |
| 2020 | $21.06 | 1 | AbbVie Inc. ($21.06) |
| 2019 | $943.16 | 54 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($494.32) |
| 2018 | $532.57 | 24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($454.39) |
| 2017 | $1,092 | 26 | Gilead Sciences Inc ($625.00) |
All Payment Transactions
447 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: GALLSTONES | ||||||
| 12/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: LIVER DISEASE | ||||||
| 12/09/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: LIVER DISEASE | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Immunology | ||||||
| 12/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: GALLSTONES | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: LIVER DISEASE | ||||||
| 11/09/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: LIVER DISEASE | ||||||
| 11/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.40 | General |
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: LIVER DISEASE | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 340 | 435 | $173,409 | $63,502 |
| 2022 | 6 | 258 | 313 | $106,604 | $42,144 |
| 2021 | 5 | 127 | 150 | $52,083 | $22,955 |
Total Patients
725
Total Services
898
Medicare Billing
$128,601
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 48 | 49 | $53,089 | $16,965 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $35,819 | $13,919 | 38.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 37 | 39 | $26,183 | $12,356 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 154 | $36,407 | $12,250 | 33.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 12 | 12 | $13,351 | $5,414 | 40.6% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 67 | 88 | $8,559 | $2,597 | 30.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 28 | 30 | $23,700 | $10,587 | 44.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 36 | 39 | $22,195 | $10,125 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $24,490 | $9,169 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 109 | $27,250 | $8,950 | 32.8% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2022 | 53 | 60 | $6,214 | $1,919 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $2,755 | $1,394 | 50.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 48 | 48 | $16,860 | $7,397 | 43.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 14 | 15 | $11,850 | $5,670 | 47.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 16 | 17 | $9,877 | $5,085 | 51.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 44 | $11,000 | $3,880 | 35.3% |
| 96360 | Hydration infusion into a vein 31 minutes to 1 hour | Office | 2021 | 23 | 26 | $2,496 | $922.74 | 37.0% |
About Dr. Nancy Chen, MD
Dr. Nancy Chen, MD is a Gastroenterology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1063742534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Chen, MD has received a total of $8,493 in payments from pharmaceutical and medical device companies, with $1,958 received in 2024. These payments were reported across 447 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($8,417).
As a Medicare-enrolled provider, Chen has provided services to 725 Medicare beneficiaries, totaling 898 services with total Medicare billing of $128,601. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Brooklyn, NY
- Active Since 01/06/2010
- Last Updated 08/08/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1063742534
Products in Payments
- XIFAXAN (Drug) $1,892
- ZEPOSIA (Drug) $541.63
- STELARA (Biological) $399.14
- Vemlidy (Drug) $375.00
- XELJANZ (Drug) $349.72
- Linzess (Drug) $302.86
- Sucraid (Drug) $282.18
- IBSRELA (Drug) $250.52
- XIFAXANIBSD (Drug) $248.39
- RESMETIROM (Drug) $201.07
- Talicia (Drug) $200.51
- RINVOQ (Biological) $188.28
- TRULANCE (Drug) $183.94
- ZENPEP (Drug) $165.51
- MAVYRET (Drug) $141.82
- RELTONE 200 MG (Drug) $123.37
- Creon (Drug) $121.82
- SKYRIZI (Biological) $117.71
- TREMFYA (Drug) $108.54
- DUPIXENT (Biological) $102.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brooklyn
Sam Moskowitz, Md, MD
Gastroenterology — Payments: $349,162
Gastroenterology $349,162
Jianjun Li, M.d, M.D
Gastroenterology — Payments: $307,830
Gastroenterology $307,830
Dr. Nison Badalov, M.d, M.D
Gastroenterology — Payments: $237,374
Gastroenterology $237,374
Smruti Mohanty, Md, Ms, MD, MS
Gastroenterology — Payments: $219,216
Gastroenterology $219,216
Dr. Jonathan Erber, Md, MD
Gastroenterology — Payments: $208,708
Gastroenterology $208,708
Dr. Rabin Rahmani, M.d, M.D
Gastroenterology — Payments: $204,380
Gastroenterology $204,380